AVN-944
- CAS No.
- 297730-17-7
- Chemical Name:
- AVN-944
- Synonyms
- VX944;VX 944;VX-944;CS-1604;AVN944 (VX-944);VX 944; AVN-944;;(R)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)phenyl)ethylcarbamate;[(2R)-1-cyanobutan-2-yl] N-[(1S)-1-[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]ethyl]carbamate;Carbamic acid, N-[(1S)-1-[3-[[[[3-methoxy-4-(5-oxazolyl)phenyl]amino]carbonyl]amino]phenyl]ethyl]-, (1R)-1-(cyanomethyl)propyl ester;multiple myeloma,RPMI8226,Caspase,AVN-944,VX 944,Apoptosis,BMSCs,IMPDH,Arenavirus,Bcl-2 Family,U266 cells,inhibit,DNA/RNA Synthesis,acute myeloid leukemia,AML,MM.1S,AVN944,oncolytic activity,Inhibitor,AIF,Endo G,VX944,caspase-independent,AVN 944
- CBNumber:
- CB62668095
- Molecular Formula:
- C25H27N5O5
- Molecular Weight:
- 477.51
- MDL Number:
- MOL File:
- 297730-17-7.mol
| Boiling point | 597.4±50.0 °C(Predicted) |
|---|---|
| Density | 1.277±0.06 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility |
DMSO:PBS (pH 7.2) (1:3):0.25(Max Conc. mg/mL);0.52(Max Conc. mM) DMF:30.0(Max Conc. mg/mL);62.83(Max Conc. mM) |
| form | A crystalline solid |
| pka | 11.38±0.46(Predicted) |
| color | White to off-white |
| FDA UNII | I3NPL1V48Q |
AVN-944 price More Price(14)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | SML3440 | AVN-944 ≥98% (HPLC) | 297730-17-7 | 5MG | $79 | 2024-03-01 | Buy |
| Sigma-Aldrich | SML3440 | AVN-944 ≥98% (HPLC) | 297730-17-7 | 25MG | $319 | 2024-03-01 | Buy |
| Cayman Chemical | 21284 | AVN944 ≥98% | 297730-17-7 | 1mg | $38 | 2024-03-01 | Buy |
| Cayman Chemical | 21284 | AVN944 ≥98% | 297730-17-7 | 5mg | $111 | 2024-03-01 | Buy |
| Cayman Chemical | 21284 | AVN944 ≥98% | 297730-17-7 | 10mg | $184 | 2024-03-01 | Buy |
AVN-944 Chemical Properties,Uses,Production
Description
AVN944 is a selective, noncompetitive inhibitor of inosine-5''-monophosphate dehydrogenase (IMPDH; Ki = 6-10 nM for both human IMPDH isoforms), a rate-limiting enzyme involved in the de novo synthesis of purine nucleotides. Inhibition of IMPDH results in disruption of DNA and RNA synthesis, inhibition of cell proliferation, and the induction of apoptosis. AVN944 has been shown to inhibit the proliferation of multiple myeloma cells in vitro by inducing caspase-independent apoptosis. It is also reported to have antitumor properties in androgen-sensitive and androgen-independent prostate cancer cells in vitro.
Uses
AVN-944 is a novel inosine monophosphate dehydrogenase (IMPDH) inhibitor. It has antiproliferative effects and might be combined with other agents for treatment of human prostate cancer.This compound is suitable for pyruvate dehydrogenase (PDH) related research.
Enzyme inhibitor
This orally available antineoplastic agent (FW = 310.36 g/mol; CAS 297730-17-7), also known as VX-944 and (R)-1-cyanobutan-2-yl-(S)-1-(3- (3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)phenyl)ethyl)carbamate, inhibits inosine 5’-monophosphate dehydrogenase (IMPDH), the enzyme catalyzing the conversion of IMP into XMP, leading to the biosynthesis of GMP, GDP, GTP, and ultimately dGTP. IMPDH is overexpressed in some cancer cells, particularly in hematological malignancies, and AVN944 appears to have a selective cytotoxic effect on cancer cells. Reduction of GTP in normal cells results in a temporary slowing of cell growth only.AVN944 treatment results in dose-dependent cell growth inhibition in all studied prostate cancer cells, independently of their androgen sensitivity. AVN944 treatment arrests LNCaP cells in G1-phase and and androgen independent 22Rv1, DU145 and PC-3 cells in S-phase. AVN-944 treatment leads to the rapid disappearance of nucleostemin, a positive regulator of cell proliferation that is highly expressed in a variety of stem cells, tumors, and tumor cell lines.
AVN-944 Preparation Products And Raw materials
Raw materials
Preparation Products
AVN-944 Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| career henan chemical co | +86-0371-86658258 +8613203830695 | factory@coreychem.com | China | 29814 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32072 | 58 |
| Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10473 | 58 |
| LEAP CHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 24727 | 58 |
| ShenZhen Trendseen Biological Technology Co.,Ltd. | 13417589054 | trendseenbio@gmail.com | China | 11681 | 58 |
| Aladdin Scientific | +1-+1(833)-552-7181 | sales@aladdinsci.com | United States | 52925 | 58 |
| Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131957 | 58 |
| Shanghai Boyle Chemical Co., Ltd. | sales@boylechem.com | China | 2922 | 55 | |
| Chembest Research Laboratories Limited | +86-21-20908456 | sales@BioChemBest.com | China | 6005 | 61 |
| Haoyuan Chemexpress Co., Ltd. | 021-58950125 | info@chemexpress.com | China | 7552 | 61 |
View Lastest Price from AVN-944 manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2024-11-01 | AVN-944
297730-17-7
|
US $54.00-139.00 / mg | ≥95% | 10g | TargetMol Chemicals Inc. | ||
![[(2R)-1-cyanobutan-2-yl] N-[(1S)-1-[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]ethyl]carbamate pictures](https://img.chemicalbook.com/ProductImageEN/2020-1/Small/000a41f5-0222-4479-966f-aed4abf409ce.png) |
2020-01-02 | [(2R)-1-cyanobutan-2-yl] N-[(1S)-1-[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]ethyl]carbamate
297730-17-7
|
US $1.00 / KG | 1KG | Min98% HPLC | g/kg/ton | Career Henan Chemical Co |
-
- AVN-944
297730-17-7
- US $54.00-139.00 / mg
- ≥95%
- TargetMol Chemicals Inc.
-
- [(2R)-1-cyanobutan-2-yl] N-[(1S)-1-[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]ethyl]carbamate
297730-17-7
- US $1.00 / KG
- Min98% HPLC
- Career Henan Chemical Co